EXPEREO
14.7.2022 03:02:12 CEST | Business Wire | Press release
Expereo , the leading provider of managed Internet, Cloud Access Optimization, SASE, and SD-WAN solutions, is pleased to announce the appointments of Daniel Beevers as Managing Director EMEA and Eric Wong as Regional Director Asia Pacific as the company accelerates its growth, scaling its leadership in support of global customer base.
Beevers and Wong will lead and grow enterprise business, while driving exceptional customer experience, within their respective geographies. Both leaders are major hires for Expereo as it continues its global expansion and development, due to their strong industry experience, exceptional enterprise customer experience track records, and depth of international knowledge serving multi-national organizations.
They join Ben Elms, Chief Revenue Officer who was appointed earlier this year to accelerate growth of the company, leading Sales and go-to-market transformation across all channels driving the expansion and adoption of Expereo’s services globally.
“Asia Pacific is a key growth area for Expereo, and Eric will be instrumental in driving our ambitions for the region. We are pleased to welcome Eric as an important member of our team, supporting our customers with their digital transformation across APAC,” says Expereo’s Chief Executive Officer, Irwin Fouwels. “The addition of Dan, helps us also to focus on our core EMEA market and continue to provide solutions that ensure a smooth transition for companies looking to power-up their network capabilities and enhance global productivity. These new, but vastly experienced members of our leadership team will help us expand the global footprint and more importantly, better positions us to best meet our customers’ needs.”
Dan Beevers joins Expereo’s leadership team with more than 20 years of experience in the telecommunications industry. Leveraging his experience in executive roles throughout Europe, Asia and Australia, Beevers will have a keen focus on developing world-class sales teams and driving enterprise sales across EMEA markets.
“I’m excited to join Expereo at this transformative time and help to build on an already solid foundation,” said Dan Beevers, Managing Director, EMEA. “Expereo is perfectly positioned to help clients digitally transform their business and compete in the modern, digital marketplace.”
Eric Wong will also draw from his 20 years of industry experience with many of the world’s largest multi-national companies to provide innovative and customer-centric solutions for Expereo’s Asia Pacific clients.
“I’m thrilled to be joining the Expereo family and to lead the next phase of growth. The digitalization megatrends across the region present an abundance of opportunities for Expereo to enable enterprises to take advantage of the connected age,” said Eric Wong, Regional Director of Asia Pacific.
Expereo continues its global growth and development by investing in regional markets. The opening of offices in the Philippines this month and Germany in August, brings the business closer to customers and further delivers on regional knowledge, providing a superior local experience around the world, delivering simplified global networks while delighting customers with seamless connectivity services from a single, trusted provider.
About Expereo
Expereo is a leading global provider of managed network solutions including, Global Internet, SD-WAN/SASE, and Enhanced Internet. With an extensive global reach, Expereo is the trusted partner of 30% of Fortune 500 companies. It powers enterprise and government sites in more than 190 countries, helping customers improve productivity and empowering their networks and cloud services with the agility, flexibility and value of the Internet, with optimal network performance.
Expereo was acquired in February 2021, by Vitruvian Partners. The international growth capital and buyout firm acquired a majority shareholding from leading European private equity firm, Apax Partners sas.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220713005752/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom